Xian Peng

Title: The Innovative Contributions of Xian Peng in Analgesic Compounds

Introduction

Xian Peng, an accomplished inventor based in Shanghai, China, has made significant strides in the field of pharmaceutical innovations. With a focus on analgesic compounds, his work has the potential to impact pain management therapies positively.

Latest Patents

Xian Peng holds a patent for "Analgesic compounds, methods, and formulations," which features unique analgesic compounds and their salts. The patented formula includes specific characteristics denoted by variable A and also outlines pharmaceutical formulations and methods of use that utilize these compounds. This invention signifies a noteworthy advancement in pain relief methodologies.

Career Highlights

Currently, Xian Peng is associated with Eli Lilly and Company, a known leader in pharmaceutical research and development. His role at Eli Lilly highlights his commitment to pushing the boundaries of medical innovation, particularly in developing effective pain relief solutions.

Collaborations

Xian has collaborated closely with talented coworkers such as Jean Marie Defauw and Scott Dale Holmstrom. These partnerships reflect a collaborative spirit within the research community, emphasizing the importance of teamwork in achieving groundbreaking inventions.

Conclusion

Xian Peng's contributions to analgesic compounds showcase his dedication to addressing critical health challenges. His patent not only highlights his innovative mindset but also marks a significant step forward in the pharmaceutical landscape, ensuring enhanced pain management options for patients in need.